AriellaKelmanMD

Crystal Related, Lupus & Related, Rheumatoid Arthritis & Related

Stanford University School of Medicine Division of Immunology and Rheumatology

Dr. Kelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stanford Health Care-Sponsored Stanford UniversityFellowship, Rheumatology, 2003 - 2005
Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 1999 - 2001
Kaiser Permanente Southern California (Los Angeles)Internship, Internal Medicine, 1998 - 1999
Tel Aviv University SacklerClass of 1998

PubMed

8 citations
Relocation of study participants for rare and ultra-rare disease trials: Ethics and operations.
Luke Gelinas, Brian Crawford, Ariella Kelman, Barbara E. Bierer
Contemporary Clinical Trials. 2019-07-19
53 citations
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis
Mark C. Genovese, Joel M. Kremer, Ronald F van Vollenhoven, Rieke Alten, Juan Jose Scali
Arthritis & Rheumatology. 2017-09-01
11 citations
Communicating laboratory test results for rheumatoid factor: what do patients and physicians want?
Ariella Kelman, Caroline O Robinson, Elisenda Cochin, Nina J Ahluwalia, Julia Braverman
Patient Preference and Adherence. 2016-12-13

Considerations for Applying Bioethics Norms to a Biopharmaceutical Industry SettingMarch 25th, 2021
Biora Therapeutics : Phase 1 Clinical Trial of BT-600 Presentation July 2024July 18th, 2024